As the global economy mends, the 2021 growth of Contraceptive Transdermal Patche will have significant change from previous year. According to our (Publisher) latest study, the global Contraceptive Transdermal Patche market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Contraceptive Transdermal Patche market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.
The United States Contraceptive Transdermal Patche market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Contraceptive Transdermal Patche market, reaching US$ million by the year 2028. As for the Europe Contraceptive Transdermal Patche landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Contraceptive Transdermal Patche players cover Mylan Nv, Ansell Limited, Bayer AG, and Church & Dwight Co., Inc., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Contraceptive Transdermal Patche market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Progestin-only Contraceptive
Combined Hormonal Contraceptive
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospitals
Household
Clinics
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Mylan Nv
Ansell Limited
Bayer AG
Church & Dwight Co., Inc.
Merck & Co., Inc.
Pfizer Inc.
Teva Pharmaceutical Industries Limited
The Cooper Companies, Inc.
The Female Health Company
Abviee Inc
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Contraceptive Transdermal Patche Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Contraceptive Transdermal Patche by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Contraceptive Transdermal Patche by Country/Region, 2017, 2022 & 2028
2.2 Contraceptive Transdermal Patche Segment by Type
2.2.1 Progestin-only Contraceptive
2.2.2 Combined Hormonal Contraceptive
2.3 Contraceptive Transdermal Patche Sales by Type
2.3.1 Global Contraceptive Transdermal Patche Sales Market Share by Type (2017-2022)
2.3.2 Global Contraceptive Transdermal Patche Revenue and Market Share by Type (2017-2022)
2.3.3 Global Contraceptive Transdermal Patche Sale Price by Type (2017-2022)
2.4 Contraceptive Transdermal Patche Segment by Application
2.4.1 Hospitals
2.4.2 Household
2.4.3 Clinics
2.5 Contraceptive Transdermal Patche Sales by Application
2.5.1 Global Contraceptive Transdermal Patche Sale Market Share by Application (2017-2022)
2.5.2 Global Contraceptive Transdermal Patche Revenue and Market Share by Application (2017-2022)
2.5.3 Global Contraceptive Transdermal Patche Sale Price by Application (2017-2022)
3 Global Contraceptive Transdermal Patche by Company
3.1 Global Contraceptive Transdermal Patche Breakdown Data by Company
3.1.1 Global Contraceptive Transdermal Patche Annual Sales by Company (2020-2022)
3.1.2 Global Contraceptive Transdermal Patche Sales Market Share by Company (2020-2022)
3.2 Global Contraceptive Transdermal Patche Annual Revenue by Company (2020-2022)
3.2.1 Global Contraceptive Transdermal Patche Revenue by Company (2020-2022)
3.2.2 Global Contraceptive Transdermal Patche Revenue Market Share by Company (2020-2022)
3.3 Global Contraceptive Transdermal Patche Sale Price by Company
3.4 Key Manufacturers Contraceptive Transdermal Patche Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Contraceptive Transdermal Patche Product Location Distribution
3.4.2 Players Contraceptive Transdermal Patche Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Contraceptive Transdermal Patche by Geographic Region
4.1 World Historic Contraceptive Transdermal Patche Market Size by Geographic Region (2017-2022)
4.1.1 Global Contraceptive Transdermal Patche Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Contraceptive Transdermal Patche Annual Revenue by Geographic Region
4.2 World Historic Contraceptive Transdermal Patche Market Size by Country/Region (2017-2022)
4.2.1 Global Contraceptive Transdermal Patche Annual Sales by Country/Region (2017-2022)
4.2.2 Global Contraceptive Transdermal Patche Annual Revenue by Country/Region
4.3 Americas Contraceptive Transdermal Patche Sales Growth
4.4 APAC Contraceptive Transdermal Patche Sales Growth
4.5 Europe Contraceptive Transdermal Patche Sales Growth
4.6 Middle East & Africa Contraceptive Transdermal Patche Sales Growth
5 Americas
5.1 Americas Contraceptive Transdermal Patche Sales by Country
5.1.1 Americas Contraceptive Transdermal Patche Sales by Country (2017-2022)
5.1.2 Americas Contraceptive Transdermal Patche Revenue by Country (2017-2022)
5.2 Americas Contraceptive Transdermal Patche Sales by Type
5.3 Americas Contraceptive Transdermal Patche Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Contraceptive Transdermal Patche Sales by Region
6.1.1 APAC Contraceptive Transdermal Patche Sales by Region (2017-2022)
6.1.2 APAC Contraceptive Transdermal Patche Revenue by Region (2017-2022)
6.2 APAC Contraceptive Transdermal Patche Sales by Type
6.3 APAC Contraceptive Transdermal Patche Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Contraceptive Transdermal Patche by Country
7.1.1 Europe Contraceptive Transdermal Patche Sales by Country (2017-2022)
7.1.2 Europe Contraceptive Transdermal Patche Revenue by Country (2017-2022)
7.2 Europe Contraceptive Transdermal Patche Sales by Type
7.3 Europe Contraceptive Transdermal Patche Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Contraceptive Transdermal Patche by Country
8.1.1 Middle East & Africa Contraceptive Transdermal Patche Sales by Country (2017-2022)
8.1.2 Middle East & Africa Contraceptive Transdermal Patche Revenue by Country (2017-2022)
8.2 Middle East & Africa Contraceptive Transdermal Patche Sales by Type
8.3 Middle East & Africa Contraceptive Transdermal Patche Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Contraceptive Transdermal Patche
10.3 Manufacturing Process Analysis of Contraceptive Transdermal Patche
10.4 Industry Chain Structure of Contraceptive Transdermal Patche
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Contraceptive Transdermal Patche Distributors
11.3 Contraceptive Transdermal Patche Customer
12 World Forecast Review for Contraceptive Transdermal Patche by Geographic Region
12.1 Global Contraceptive Transdermal Patche Market Size Forecast by Region
12.1.1 Global Contraceptive Transdermal Patche Forecast by Region (2023-2028)
12.1.2 Global Contraceptive Transdermal Patche Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Contraceptive Transdermal Patche Forecast by Type
12.7 Global Contraceptive Transdermal Patche Forecast by Application
13 Key Players Analysis
13.1 Mylan Nv
13.1.1 Mylan Nv Company Information
13.1.2 Mylan Nv Contraceptive Transdermal Patche Product Offered
13.1.3 Mylan Nv Contraceptive Transdermal Patche Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Mylan Nv Main Business Overview
13.1.5 Mylan Nv Latest Developments
13.2 Ansell Limited
13.2.1 Ansell Limited Company Information
13.2.2 Ansell Limited Contraceptive Transdermal Patche Product Offered
13.2.3 Ansell Limited Contraceptive Transdermal Patche Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Ansell Limited Main Business Overview
13.2.5 Ansell Limited Latest Developments
13.3 Bayer AG
13.3.1 Bayer AG Company Information
13.3.2 Bayer AG Contraceptive Transdermal Patche Product Offered
13.3.3 Bayer AG Contraceptive Transdermal Patche Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Bayer AG Main Business Overview
13.3.5 Bayer AG Latest Developments
13.4 Church & Dwight Co., Inc.
13.4.1 Church & Dwight Co., Inc. Company Information
13.4.2 Church & Dwight Co., Inc. Contraceptive Transdermal Patche Product Offered
13.4.3 Church & Dwight Co., Inc. Contraceptive Transdermal Patche Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Church & Dwight Co., Inc. Main Business Overview
13.4.5 Church & Dwight Co., Inc. Latest Developments
13.5 Merck & Co., Inc.
13.5.1 Merck & Co., Inc. Company Information
13.5.2 Merck & Co., Inc. Contraceptive Transdermal Patche Product Offered
13.5.3 Merck & Co., Inc. Contraceptive Transdermal Patche Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Merck & Co., Inc. Main Business Overview
13.5.5 Merck & Co., Inc. Latest Developments
13.6 Pfizer Inc.
13.6.1 Pfizer Inc. Company Information
13.6.2 Pfizer Inc. Contraceptive Transdermal Patche Product Offered
13.6.3 Pfizer Inc. Contraceptive Transdermal Patche Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Pfizer Inc. Main Business Overview
13.6.5 Pfizer Inc. Latest Developments
13.7 Teva Pharmaceutical Industries Limited
13.7.1 Teva Pharmaceutical Industries Limited Company Information
13.7.2 Teva Pharmaceutical Industries Limited Contraceptive Transdermal Patche Product Offered
13.7.3 Teva Pharmaceutical Industries Limited Contraceptive Transdermal Patche Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Teva Pharmaceutical Industries Limited Main Business Overview
13.7.5 Teva Pharmaceutical Industries Limited Latest Developments
13.8 The Cooper Companies, Inc.
13.8.1 The Cooper Companies, Inc. Company Information
13.8.2 The Cooper Companies, Inc. Contraceptive Transdermal Patche Product Offered
13.8.3 The Cooper Companies, Inc. Contraceptive Transdermal Patche Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 The Cooper Companies, Inc. Main Business Overview
13.8.5 The Cooper Companies, Inc. Latest Developments
13.9 The Female Health Company
13.9.1 The Female Health Company Company Information
13.9.2 The Female Health Company Contraceptive Transdermal Patche Product Offered
13.9.3 The Female Health Company Contraceptive Transdermal Patche Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 The Female Health Company Main Business Overview
13.9.5 The Female Health Company Latest Developments
13.10 Abviee Inc
13.10.1 Abviee Inc Company Information
13.10.2 Abviee Inc Contraceptive Transdermal Patche Product Offered
13.10.3 Abviee Inc Contraceptive Transdermal Patche Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Abviee Inc Main Business Overview
13.10.5 Abviee Inc Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Contraceptive Transdermal Patche Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Contraceptive Transdermal Patche Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Progestin-only Contraceptive
Table 4. Major Players of Combined Hormonal Contraceptive
Table 5. Global Contraceptive Transdermal Patche Sales by Type (2017-2022) & (K Units)
Table 6. Global Contraceptive Transdermal Patche Sales Market Share by Type (2017-2022)
Table 7. Global Contraceptive Transdermal Patche Revenue by Type (2017-2022) & ($ million)
Table 8. Global Contraceptive Transdermal Patche Revenue Market Share by Type (2017-2022)
Table 9. Global Contraceptive Transdermal Patche Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Contraceptive Transdermal Patche Sales by Application (2017-2022) & (K Units)
Table 11. Global Contraceptive Transdermal Patche Sales Market Share by Application (2017-2022)
Table 12. Global Contraceptive Transdermal Patche Revenue by Application (2017-2022)
Table 13. Global Contraceptive Transdermal Patche Revenue Market Share by Application (2017-2022)
Table 14. Global Contraceptive Transdermal Patche Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Contraceptive Transdermal Patche Sales by Company (2020-2022) & (K Units)
Table 16. Global Contraceptive Transdermal Patche Sales Market Share by Company (2020-2022)
Table 17. Global Contraceptive Transdermal Patche Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Contraceptive Transdermal Patche Revenue Market Share by Company (2020-2022)
Table 19. Global Contraceptive Transdermal Patche Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Contraceptive Transdermal Patche Producing Area Distribution and Sales Area
Table 21. Players Contraceptive Transdermal Patche Products Offered
Table 22. Contraceptive Transdermal Patche Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Contraceptive Transdermal Patche Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Contraceptive Transdermal Patche Sales Market Share Geographic Region (2017-2022)
Table 27. Global Contraceptive Transdermal Patche Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Contraceptive Transdermal Patche Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Contraceptive Transdermal Patche Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Contraceptive Transdermal Patche Sales Market Share by Country/Region (2017-2022)
Table 31. Global Contraceptive Transdermal Patche Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Contraceptive Transdermal Patche Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Contraceptive Transdermal Patche Sales by Country (2017-2022) & (K Units)
Table 34. Americas Contraceptive Transdermal Patche Sales Market Share by Country (2017-2022)
Table 35. Americas Contraceptive Transdermal Patche Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Contraceptive Transdermal Patche Revenue Market Share by Country (2017-2022)
Table 37. Americas Contraceptive Transdermal Patche Sales by Type (2017-2022) & (K Units)
Table 38. Americas Contraceptive Transdermal Patche Sales Market Share by Type (2017-2022)
Table 39. Americas Contraceptive Transdermal Patche Sales by Application (2017-2022) & (K Units)
Table 40. Americas Contraceptive Transdermal Patche Sales Market Share by Application (2017-2022)
Table 41. APAC Contraceptive Transdermal Patche Sales by Region (2017-2022) & (K Units)
Table 42. APAC Contraceptive Transdermal Patche Sales Market Share by Region (2017-2022)
Table 43. APAC Contraceptive Transdermal Patche Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Contraceptive Transdermal Patche Revenue Market Share by Region (2017-2022)
Table 45. APAC Contraceptive Transdermal Patche Sales by Type (2017-2022) & (K Units)
Table 46. APAC Contraceptive Transdermal Patche Sales Market Share by Type (2017-2022)
Table 47. APAC Contraceptive Transdermal Patche Sales by Application (2017-2022) & (K Units)
Table 48. APAC Contraceptive Transdermal Patche Sales Market Share by Application (2017-2022)
Table 49. Europe Contraceptive Transdermal Patche Sales by Country (2017-2022) & (K Units)
Table 50. Europe Contraceptive Transdermal Patche Sales Market Share by Country (2017-2022)
Table 51. Europe Contraceptive Transdermal Patche Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Contraceptive Transdermal Patche Revenue Market Share by Country (2017-2022)
Table 53. Europe Contraceptive Transdermal Patche Sales by Type (2017-2022) & (K Units)
Table 54. Europe Contraceptive Transdermal Patche Sales Market Share by Type (2017-2022)
Table 55. Europe Contraceptive Transdermal Patche Sales by Application (2017-2022) & (K Units)
Table 56. Europe Contraceptive Transdermal Patche Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Contraceptive Transdermal Patche Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Contraceptive Transdermal Patche Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Contraceptive Transdermal Patche Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Contraceptive Transdermal Patche Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Contraceptive Transdermal Patche Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Contraceptive Transdermal Patche Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Contraceptive Transdermal Patche Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Contraceptive Transdermal Patche Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Contraceptive Transdermal Patche
Table 66. Key Market Challenges & Risks of Contraceptive Transdermal Patche
Table 67. Key Industry Trends of Contraceptive Transdermal Patche
Table 68. Contraceptive Transdermal Patche Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Contraceptive Transdermal Patche Distributors List
Table 71. Contraceptive Transdermal Patche Customer List
Table 72. Global Contraceptive Transdermal Patche Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Contraceptive Transdermal Patche Sales Market Forecast by Region
Table 74. Global Contraceptive Transdermal Patche Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Contraceptive Transdermal Patche Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Contraceptive Transdermal Patche Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Contraceptive Transdermal Patche Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Contraceptive Transdermal Patche Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Contraceptive Transdermal Patche Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Contraceptive Transdermal Patche Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Contraceptive Transdermal Patche Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Contraceptive Transdermal Patche Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Contraceptive Transdermal Patche Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Contraceptive Transdermal Patche Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Contraceptive Transdermal Patche Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Contraceptive Transdermal Patche Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Contraceptive Transdermal Patche Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Contraceptive Transdermal Patche Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Contraceptive Transdermal Patche Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Contraceptive Transdermal Patche Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Contraceptive Transdermal Patche Revenue Market Share Forecast by Application (2023-2028)
Table 92. Mylan Nv Basic Information, Contraceptive Transdermal Patche Manufacturing Base, Sales Area and Its Competitors
Table 93. Mylan Nv Contraceptive Transdermal Patche Product Offered
Table 94. Mylan Nv Contraceptive Transdermal Patche Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Mylan Nv Main Business
Table 96. Mylan Nv Latest Developments
Table 97. Ansell Limited Basic Information, Contraceptive Transdermal Patche Manufacturing Base, Sales Area and Its Competitors
Table 98. Ansell Limited Contraceptive Transdermal Patche Product Offered
Table 99. Ansell Limited Contraceptive Transdermal Patche Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Ansell Limited Main Business
Table 101. Ansell Limited Latest Developments
Table 102. Bayer AG Basic Information, Contraceptive Transdermal Patche Manufacturing Base, Sales Area and Its Competitors
Table 103. Bayer AG Contraceptive Transdermal Patche Product Offered
Table 104. Bayer AG Contraceptive Transdermal Patche Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Bayer AG Main Business
Table 106. Bayer AG Latest Developments
Table 107. Church & Dwight Co., Inc. Basic Information, Contraceptive Transdermal Patche Manufacturing Base, Sales Area and Its Competitors
Table 108. Church & Dwight Co., Inc. Contraceptive Transdermal Patche Product Offered
Table 109. Church & Dwight Co., Inc. Contraceptive Transdermal Patche Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Church & Dwight Co., Inc. Main Business
Table 111. Church & Dwight Co., Inc. Latest Developments
Table 112. Merck & Co., Inc. Basic Information, Contraceptive Transdermal Patche Manufacturing Base, Sales Area and Its Competitors
Table 113. Merck & Co., Inc. Contraceptive Transdermal Patche Product Offered
Table 114. Merck & Co., Inc. Contraceptive Transdermal Patche Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Merck & Co., Inc. Main Business
Table 116. Merck & Co., Inc. Latest Developments
Table 117. Pfizer Inc. Basic Information, Contraceptive Transdermal Patche Manufacturing Base, Sales Area and Its Competitors
Table 118. Pfizer Inc. Contraceptive Transdermal Patche Product Offered
Table 119. Pfizer Inc. Contraceptive Transdermal Patche Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Pfizer Inc. Main Business
Table 121. Pfizer Inc. Latest Developments
Table 122. Teva Pharmaceutical Industries Limited Basic Information, Contraceptive Transdermal Patche Manufacturing Base, Sales Area and Its Competitors
Table 123. Teva Pharmaceutical Industries Limited Contraceptive Transdermal Patche Product Offered
Table 124. Teva Pharmaceutical Industries Limited Contraceptive Transdermal Patche Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Teva Pharmaceutical Industries Limited Main Business
Table 126. Teva Pharmaceutical Industries Limited Latest Developments
Table 127. The Cooper Companies, Inc. Basic Information, Contraceptive Transdermal Patche Manufacturing Base, Sales Area and Its Competitors
Table 128. The Cooper Companies, Inc. Contraceptive Transdermal Patche Product Offered
Table 129. The Cooper Companies, Inc. Contraceptive Transdermal Patche Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. The Cooper Companies, Inc. Main Business
Table 131. The Cooper Companies, Inc. Latest Developments
Table 132. The Female Health Company Basic Information, Contraceptive Transdermal Patche Manufacturing Base, Sales Area and Its Competitors
Table 133. The Female Health Company Contraceptive Transdermal Patche Product Offered
Table 134. The Female Health Company Contraceptive Transdermal Patche Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. The Female Health Company Main Business
Table 136. The Female Health Company Latest Developments
Table 137. Abviee Inc Basic Information, Contraceptive Transdermal Patche Manufacturing Base, Sales Area and Its Competitors
Table 138. Abviee Inc Contraceptive Transdermal Patche Product Offered
Table 139. Abviee Inc Contraceptive Transdermal Patche Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. Abviee Inc Main Business
Table 141. Abviee Inc Latest Developments
List of Figures
Figure 1. Picture of Contraceptive Transdermal Patche
Figure 2. Contraceptive Transdermal Patche Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Contraceptive Transdermal Patche Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Contraceptive Transdermal Patche Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Contraceptive Transdermal Patche Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Progestin-only Contraceptive
Figure 10. Product Picture of Combined Hormonal Contraceptive
Figure 11. Global Contraceptive Transdermal Patche Sales Market Share by Type in 2021
Figure 12. Global Contraceptive Transdermal Patche Revenue Market Share by Type (2017-2022)
Figure 13. Contraceptive Transdermal Patche Consumed in Hospitals
Figure 14. Global Contraceptive Transdermal Patche Market: Hospitals (2017-2022) & (K Units)
Figure 15. Contraceptive Transdermal Patche Consumed in Household
Figure 16. Global Contraceptive Transdermal Patche Market: Household (2017-2022) & (K Units)
Figure 17. Contraceptive Transdermal Patche Consumed in Clinics
Figure 18. Global Contraceptive Transdermal Patche Market: Clinics (2017-2022) & (K Units)
Figure 19. Global Contraceptive Transdermal Patche Sales Market Share by Application (2017-2022)
Figure 20. Global Contraceptive Transdermal Patche Revenue Market Share by Application in 2021
Figure 21. Contraceptive Transdermal Patche Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Contraceptive Transdermal Patche Revenue Market Share by Company in 2021
Figure 23. Global Contraceptive Transdermal Patche Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Contraceptive Transdermal Patche Revenue Market Share by Geographic Region in 2021
Figure 25. Global Contraceptive Transdermal Patche Sales Market Share by Region (2017-2022)
Figure 26. Global Contraceptive Transdermal Patche Revenue Market Share by Country/Region in 2021
Figure 27. Americas Contraceptive Transdermal Patche Sales 2017-2022 (K Units)
Figure 28. Americas Contraceptive Transdermal Patche Revenue 2017-2022 ($ Millions)
Figure 29. APAC Contraceptive Transdermal Patche Sales 2017-2022 (K Units)
Figure 30. APAC Contraceptive Transdermal Patche Revenue 2017-2022 ($ Millions)
Figure 31. Europe Contraceptive Transdermal Patche Sales 2017-2022 (K Units)
Figure 32. Europe Contraceptive Transdermal Patche Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Contraceptive Transdermal Patche Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Contraceptive Transdermal Patche Revenue 2017-2022 ($ Millions)
Figure 35. Americas Contraceptive Transdermal Patche Sales Market Share by Country in 2021
Figure 36. Americas Contraceptive Transdermal Patche Revenue Market Share by Country in 2021
Figure 37. United States Contraceptive Transdermal Patche Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Contraceptive Transdermal Patche Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Contraceptive Transdermal Patche Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Contraceptive Transdermal Patche Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Contraceptive Transdermal Patche Sales Market Share by Region in 2021
Figure 42. APAC Contraceptive Transdermal Patche Revenue Market Share by Regions in 2021
Figure 43. China Contraceptive Transdermal Patche Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Contraceptive Transdermal Patche Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Contraceptive Transdermal Patche Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Contraceptive Transdermal Patche Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Contraceptive Transdermal Patche Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Contraceptive Transdermal Patche Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Contraceptive Transdermal Patche Sales Market Share by Country in 2021
Figure 50. Europe Contraceptive Transdermal Patche Revenue Market Share by Country in 2021
Figure 51. Germany Contraceptive Transdermal Patche Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Contraceptive Transdermal Patche Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Contraceptive Transdermal Patche Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Contraceptive Transdermal Patche Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Contraceptive Transdermal Patche Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Contraceptive Transdermal Patche Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Contraceptive Transdermal Patche Revenue Market Share by Country in 2021
Figure 58. Egypt Contraceptive Transdermal Patche Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Contraceptive Transdermal Patche Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Contraceptive Transdermal Patche Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Contraceptive Transdermal Patche Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Contraceptive Transdermal Patche Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Contraceptive Transdermal Patche in 2021
Figure 64. Manufacturing Process Analysis of Contraceptive Transdermal Patche
Figure 65. Industry Chain Structure of Contraceptive Transdermal Patche
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)